Extracorporeal membrane oxygenation (ECMO) is the provision of long‐term support for severe, potentially reversible cardiopulmonary failure through the use of extrathoracic cannulation and an extracorporeal circuit. The extracorporeal circuit is a modification of the heart‐lung machine used in cardiac bypass surgery and consists of a drainage reservoir, blood pump, artificial lung for oxygen and carbon dioxide exchange, a heat exchanger for maintenance of body temperature, cannulae for vascular access, and connecting tubing. ECMO is used in the management of severe, acute, potentially reversible cardiopulmonary failure in neonates, children, and adults. The modes of support include venoarterial (VA), venovenous (VV), arteriovenous (AV), and hybrid VA and VV (VVA). Venoarterial support bypasses the heart and lungs and provides cardiac and pulmonary support. Venovenous provides gas exchange in the central venous circulation, and it provides pulmonary support only. Arteriovenous is performed using an artificial lung without a pump, but provides carbon dioxide removal only. VVA mode combines partial cardiac support in addition to pulmonary support.
The performance of the ECMO circuit depends on several factors. Blood flow is dependent on geometry of the vascular cannulae, tubing, and artificial lung, and it includes laminar and turbulent flow. Pressure‐flow relationships for ECMO circuit components have been published. Gas exchange efficiency in venovenous ECMO is affected by recirculation. The determinants of artificial lung gas transfer are complex but based on principles of passive diffusion. Modern cross‐flow hollow fiber devices that have blood flow exterior to the fibers demonstrate the best blood flow and gas transfer performance.